Ke Xu Selected Research

Hemorrhage

10/2022	New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans.
1/2022	Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
9/2021	Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update.
5/2021	Evolution, progress, and prospects of research on transjugular intrahepatic portosystemic shunt applications.
9/2020	Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?-A Systematic Review.
1/2020	The conundrum of resuming anticoagulant therapy after intracerebral bleeding: In whom, when, and how?
9/2019	Bleeding in patients with atrial fibrillation treated with combined antiplatelet and anticoagulant therapy: time to turn the corner.
1/2019	Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion.
11/2018	In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets.
11/2018	Clinical pharmacodynamics and long-term efficacy of Talcom vs. Plavix in patients undergoing coronary stent implantation: a randomized study with 5-year follow-up.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ke Xu Research Topics

Disease

229	Neoplasms (Cancer) 05/2024 - 09/2005
60	Infections 05/2024 - 09/2004
60	Neoplasm Metastasis (Metastasis) 05/2024 - 06/2010
54	Myocardial Infarction 01/2019 - 06/2011
50	Inflammation (Inflammations) 04/2024 - 02/2015
45	Lung Neoplasms (Lung Cancer) 10/2023 - 02/2004
38	Hemorrhage 10/2022 - 06/2011
38	ST Elevation Myocardial Infarction 10/2017 - 10/2011
37	Thrombosis (Thrombus) 01/2024 - 04/2009
33	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2004
33	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 08/2012
32	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 09/2011
31	Acute Coronary Syndrome 01/2019 - 06/2011
29	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 04/2009
25	Rheumatoid Arthritis 12/2023 - 09/2012
24	COVID-19 05/2024 - 01/2020
22	Carcinogenesis 03/2024 - 06/2010
21	Stroke (Strokes) 11/2023 - 01/2014
20	Glioma (Gliomas) 01/2023 - 08/2010
19	Osteoarthritis 07/2024 - 01/2018
18	Pain (Aches) 01/2024 - 02/2003
16	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 10/2011
16	Necrosis 01/2023 - 02/2011
15	Fibrosis (Cirrhosis) 02/2024 - 08/2017
15	Schizophrenia (Dementia Praecox) 11/2023 - 07/2003
14	Rupture 02/2024 - 02/2007
14	Aortic Valve Stenosis (Aortic Stenosis) 11/2023 - 01/2014
13	Hypoxia (Hypoxemia) 02/2024 - 01/2009
13	Wounds and Injuries (Trauma) 01/2024 - 01/2018
13	Infarction (Infarctions) 07/2023 - 02/2011
11	Pathologic Constriction (Stenosis) 11/2023 - 03/2007
11	Hypertension (High Blood Pressure) 09/2023 - 06/2012
11	Atherosclerosis 09/2023 - 03/2012
11	Acute Kidney Injury (Acute Renal Failure) 04/2023 - 12/2012
10	Cognitive Dysfunction 04/2024 - 07/2012
10	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2013
10	Death (Near-Death Experience) 01/2021 - 09/2011
9	Disease Progression 05/2024 - 12/2013
9	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2021
9	Heart Failure 02/2024 - 05/2014
9	Lymphatic Metastasis 01/2021 - 04/2007
8	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 09/2019
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2012
8	Atherosclerotic Plaque (Atheroma) 12/2022 - 03/2012
8	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 04/2011

Drug/Important Bio-Agent (IBA)

68	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2011
67	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2006
35	MicroRNAs (MicroRNA)IBA 03/2024 - 02/2010
22	CytokinesIBA 04/2024 - 06/2011
21	RNA (Ribonucleic Acid)IBA 12/2023 - 03/2005
21	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2012
20	Therapeutic UsesIBA 04/2024 - 12/2012
18	Messenger RNA (mRNA)IBA 12/2023 - 01/2009
17	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 12/2014
16	LipidsIBA 05/2024 - 12/2014
16	EnzymesIBA 04/2024 - 07/2003
15	VaccinesIBA 05/2024 - 12/2010
13	Small Interfering RNA (siRNA)IBA 07/2024 - 08/2006
13	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2011
13	Transcription Factors (Transcription Factor)IBA 07/2023 - 01/2011
13	bivalirudin (Angiomax)FDA Link 02/2015 - 06/2011
11	Immune Checkpoint InhibitorsIBA 03/2024 - 07/2021
11	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2023 - 05/2013
11	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 06/2011
10	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2014
10	InterferonsIBA 03/2024 - 06/2012
10	Interleukin-6 (Interleukin 6)IBA 02/2024 - 08/2012
10	AntioxidantsIBA 01/2024 - 01/2019
10	Long Noncoding RNAIBA 10/2023 - 01/2018
10	Neutralizing AntibodiesIBA 01/2023 - 01/2009
9	bufalinIBA 02/2024 - 07/2017
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 01/2011
9	CollagenIBA 11/2023 - 12/2008
9	CreatinineIBA 01/2021 - 06/2011
8	Insulin (Novolin)FDA Link 05/2024 - 12/2011
8	HydrogelsIBA 04/2024 - 01/2018
8	AlbuminsIBA 02/2024 - 06/2015
8	6-methyladenineIBA 02/2024 - 12/2022
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 03/2012
8	CalciumIBA 10/2023 - 03/2012
8	Glycoproteins (Glycoprotein)IBA 08/2023 - 05/2012
8	AntibodiesIBA 04/2023 - 05/2013
8	AntigensIBA 08/2022 - 09/2004
8	C-Reactive ProteinIBA 04/2022 - 05/2013
8	Clopidogrel (Plavix)FDA Link 01/2022 - 08/2013
8	CateninsIBA 04/2021 - 11/2012
8	Peptides (Polypeptides)IBA 01/2020 - 01/2012
8	Pancreatic Elastase (Elastase)IBA 11/2015 - 11/2012
7	Antiviral Agents (Antivirals)IBA 05/2024 - 06/2013

Therapy/Procedure

159	Therapeutics 04/2024 - 02/2004
60	Percutaneous Coronary Intervention 01/2023 - 06/2011
60	Stents 01/2022 - 03/2007
38	Drug Therapy (Chemotherapy) 04/2024 - 02/2004
24	Immunotherapy 05/2024 - 08/2010
17	Transcatheter Aortic Valve Replacement 11/2023 - 03/2014
15	Radiotherapy 04/2024 - 02/2004
12	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2016 - 10/2011
10	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 07/2017
10	Patient Readmission 02/2024 - 03/2012
10	Aftercare (After-Treatment) 11/2023 - 10/2008